BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11505)

  • 1. Does myocardial adenyl cyclase represent the cardiac beta-receptor?
    Strosberg AM; Waterbury LD
    Proc West Pharmacol Soc; 1976; 19():466-9. PubMed ID: 11505
    [No Abstract]   [Full Text] [Related]  

  • 2. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.
    Lemoine H; Bilski A; Kaumann AJ
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac beta-adrenoceptors and adenylyl cyclase activity in rabbit heart during conditions of altered sympathetic activity.
    Bobik A; Korner P; Carson V; Oliver JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I43-4. PubMed ID: 6247093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic receptors and responses in the heart.
    Reuter H; Porzig H
    Postgrad Med J; 1981; 57 Suppl 1():62-70. PubMed ID: 6272252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications.
    Chemnitius JM; Bing RJ
    Can J Cardiol; 1985; 1(3):186-90. PubMed ID: 2864992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle.
    Hedberg A; Mattsson H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):798-808. PubMed ID: 6117657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between amphetamine and catecholamines on cardiac phosphorylase and adenyl cyclase.
    McNeill JH; Muschek LD
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):236-44. PubMed ID: 5031138
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of tazolol on beta-adrenoceptors in isolated preparations of the guinea-pig and rat.
    Clark SJ; Poyser RH
    J Pharm Pharmacol; 1977 Oct; 29(10):630-2. PubMed ID: 21245
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Adrenergic receptors in heart muscle: similarity of apparent affinities of beta-blockers for receptors mediating adenyl-cyclase activity, inotropic and chronotropic effects of catecholamines.
    Kaumann AJ; Birnbaumer L
    Acta Physiol Lat Am; 1973; 23(6):619-20. PubMed ID: 4153011
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone regulates ontogeny of beta adrenergic receptors and adenylate cyclase in rat heart and kidney: effects of propylthiouracil-induced perinatal hypothyroidism.
    Pracyk JB; Slotkin TA
    J Pharmacol Exp Ther; 1992 Jun; 261(3):951-8. PubMed ID: 1318378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.
    Nagai K; Murakami T; Iwase T; Tomita T; Sasayama S
    J Clin Invest; 1996 Jan; 97(1):6-13. PubMed ID: 8550851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial cell adenyl cyclase activity and the effect of thyrocalcitonin].
    Barabanova VV
    Fiziol Zh SSSR Im I M Sechenova; 1976 Sep; 62(9):1355-60. PubMed ID: 188692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.